Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.

Journal: Frontiers in pharmacology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Strilić D, Stanimirov B, Pavlović N, et al. (2026). "Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.". Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1831882